The different patient characteristics (shown in Table 1) suggested that the CRC was similar in male and female patients in terms of age group (age ≤ 40 years, vs. >40 years), location of the tumor, pathological staging, grade, KRAS mutation status and BRAF mutation status. This evidence concerns the gene BRAF and neoplasm.